Related Experiment Video
Updated: Aug 11, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Therapeutic approaches to lysosomal storage diseases
1Massachusetts General Hospital, Boston, Massachusetts, 02111, USA.
Abstract:
Nascent therapies for the lysosomal storage diseases have begun. The replacement enzyme therapy for Gaucher's disease now includes a recombinant form, and effective dosing schedules are being developed. Bone marrow transplantation appears to be a very successful treatment for nonneuronopathic Gaucher's disease and halts the progression of other lysosomal storage disorders. Following the success of bone marrow transplantation, gene therapy trials using transduced human hematopoietic cells are beginning in Gaucher's disease, which should lead to autologous bone marrow transplantation using genetically engineered cells. Experimental studies hold promise for neurologic treatment in the lysosomal storage diseases using transplanted recombinant cells and neural progenitor cells.
Related Concept Videos
Lysosomes
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Lysosomal Hydrolases
Pharmacogenomics: Identification of New Drug Targets
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Microorganisms in Medicine and Therapeutics

